RevMab

anti-Napsin-A (human), Rabbit Monoclonal (RM366)

CHF 459.00
In stock
REV-31-1252-00-R100100 µlCHF 459.00
More Information
Product Details
Synonyms Aspartyl Protease 4; ASP4; Napsin-1; TA01/TA02
Product Type Recombinant Antibody
Properties
Clone RM366
Isotype Rabbit IgG
Source/Host Rabbit
Immunogen/Antigen A peptide corresponding to the N-terminus of human Napsin-A.
Application

Immunohistochemistry (IHC): 1:500-1:1000 dilution
Western Blot (WB): 1:1000-1:2000 dilution

Crossreactivity Human
Specificity

This antibody reacts human Napsin-A.

Purity Protein A purified.
Purity Detail Protein A affinity purified from an animal origin-free culture supernatant.
Concentration N/A
Formulation Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide.
Isotype Negative Control

Rabbit IgG

Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Accession Number O96009
Declaration Manufactured by RevMab Biosciences.
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Napsin-A is an aspartic proteinase that is abundantly expressed in normal lung and kidney tissue and is also frequently expressed in lung adenocarcinomas. Napsin-A has a role in processing pulmonary surfactant B protein produced by alveolar type II pneumocytes, therefore, it has been reported to be a good diagnostic marker for the confirmation of primary lung adenocarcinoma together with thyroid transcription factor 1 (TTF-1). Expression of napsin A is also observed in the fetal kidney and proximal tubules of the adult kidney, where it is most likely involved in protein catabolism. In neoplasms other than lung cancer, napsin A expression is most frequently observed in papillary renal carcinoma (79%), followed by other subtypes of renal cell carcinoma and thyroid carcinoma.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.